BTEK.L vs. XLK
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Technology Select Sector SPDR Fund (XLK).
BTEK.L and XLK are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017. XLK is a passively managed fund by State Street that tracks the performance of the Technology Select Sector Index. It was launched on Dec 16, 1998. Both BTEK.L and XLK are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTEK.L or XLK.
Key characteristics
| BTEK.L | XLK | |
|---|---|---|
| YTD Return | 1.02% | 7.47% |
| 1Y Return | 3.42% | 37.92% |
| 3Y Return (Ann) | 2.07% | 15.99% |
| 5Y Return (Ann) | 6.59% | 23.65% |
| Sharpe Ratio | 0.35 | 2.11 |
| Daily Std Dev | 15.01% | 17.89% |
| Max Drawdown | -30.86% | -82.05% |
| Current Drawdown | -10.61% | -1.98% |
Correlation
The correlation between BTEK.L and XLK is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BTEK.L vs. XLK - Performance Comparison
In the year-to-date period, BTEK.L achieves a 1.02% return, which is significantly lower than XLK's 7.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BTEK.L vs. XLK - Expense Ratio Comparison
BTEK.L has a 0.35% expense ratio, which is higher than XLK's 0.13% expense ratio.
Risk-Adjusted Performance
BTEK.L vs. XLK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Technology Select Sector SPDR Fund (XLK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BTEK.L vs. XLK - Dividend Comparison
BTEK.L has not paid dividends to shareholders, while XLK's dividend yield for the trailing twelve months is around 0.72%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLK Technology Select Sector SPDR Fund | 0.72% | 0.76% | 1.04% | 0.65% | 0.92% | 1.16% | 1.60% | 1.37% | 1.74% | 1.79% | 1.75% | 1.70% |
Drawdowns
BTEK.L vs. XLK - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -30.86%, smaller than the maximum XLK drawdown of -82.05%. Use the drawdown chart below to compare losses from any high point for BTEK.L and XLK. For additional features, visit the drawdowns tool.
Volatility
BTEK.L vs. XLK - Volatility Comparison
The current volatility for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) is 4.92%, while Technology Select Sector SPDR Fund (XLK) has a volatility of 5.58%. This indicates that BTEK.L experiences smaller price fluctuations and is considered to be less risky than XLK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.